Cited by 321Amyotrophic Lateral Sclerosis ResearchMultiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Lymphocytic Infiltrates in the Spinal Cord in Amyotrophic Lateral Sclerosis

Engelhardt, J. I., Tajti, J., Appel, S. H.·1993·Archives of Neurology

DOI 10.1001/archneur.1993.00540010026013

Open this paper in CoChat — free account

Abstract

Objective Immunohistochemical examination was undertaken to assess the presence of lymphocytes and lymphocyte subsets in the spinal cord in amyotrophic lateral sclerosis (ALS). Design Twenty-seven consecutive ALS autopsy cases and 11 consecutive disease--control autopsy cases were examined. Tissue sections were reacted with mouse monoclonal antibody to human leukocyte common antigen, or monoclonal antibody to human B-cell L26 antigen, and detected with immunoperoxidase techniques. Unfixed sections were reacted with antihuman Leu-3a and Leu-3b/CD4 or antihuman Leu-2a/CD8 mouse monoclonal antibody and then detected with peroxidase techniques. Setting Tertiary care hospital. Cases Amyotrophic lateral sclerosis and non-ALS control autopsy specimens. Main outcome measure Detection of lymphocytes by histological and immunohistochemical reactivity. Results Perivascular and intraparenchymal lymphocytic infiltrates were found in the spinal cord of 18 of 27 consecutive ALS autopsy cases. The lymphocytes possessed only T-cell markers; no B-cell markers could be demonstrated. T-helper cells were found in proximity to degenerating corticospinal tracts, while T-helper and T-suppressor/cytotoxic cells were demonstrated in ventral horns. Lymphocytes were present in the spinal cord of only one control specimen (multiple sclerosis) and in none of the remaining 10 control specimens. In ALS tissue, the lymphocytic infiltrates did not correlate with the rate of progression or stage of the disease…

Integrity signals

Registry

Crossref · 10.1001/archneur.1993.00540010026013

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A note on the use of picric acid-paraformaldehyde-glutaraldehyde fixative for correlated light and electron microscopic immunocytochemistry
Somogyi, P., & Takagi, H. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90035-5 · Cited by 572
Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue.
Kawamata, T., Akiyama, H., Yamada, T., & McGeer, P. L. (1992) · PubMed Central · Cited by 546
Expression of the histocompatibility glycoprotein HLA-DR in neurological disease
McGeer, P. L., Itagaki, S., & McGeer, E. G. (1988) · Acta Neuropathologica · doi:10.1007/bf00689592 · Cited by 420
Diagnosis of Human Lymphoma with Monoclonal Antileukocyte Antibodies
Warnke, R. A., Gatter, K. C., Falini, B., Hildreth, P. D. K., Woolston, R.-E., Pulford, K. A. F., Cordell, J., Cohen, B., Wolf‐Peeters, C. D., & Mason, D. Y. (1983) · New England Journal of Medicine · doi:10.1056/nejm198311243092102 · Cited by 366
Antibodies to membrane structures that distinguish suppressor/cytotoxic and helper T lymphocyte subpopulations block the mixed leukocyte reaction in man.
Engleman, E. G., Benike, C. J., Glickman, E., & Evans, R. L. (1981) · The Journal of Experimental Medicine · doi:10.1084/jem.154.1.193 · Cited by 301
IgG Reactivity in the Spinal Cord and Motor Cortex in Amyotrophic Lateral Sclerosis
Engelhardt, J. I., & Appel, S. H. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530110068019 · Cited by 221
Self-citation
Serum antibodies to GM 1 ganglioside in amyotrophic lateral sclerosis
Pestronk, A., Adams, R. N., Clawson, L., Cornblath, D. R., Kuncl, R. W., Griffin, D. E., & Drachman, D. B. (1988) · Neurology · doi:10.1212/wnl.38.9.1457 · Cited by 152
Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues.
Cartun, R. W., Coles, F. B., & Pastuszak, W. (1987) · PubMed · Cited by 139
Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis
Lampson, L. A., Kushner, P. D., & Sobel, R. A. (1990) · Annals of Neurology · doi:10.1002/ana.410280311 · Cited by 128
Amyotrophic Lateral Sclerosis
Appel, S. H. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520030026007 · Cited by 105
Self-citation

Show all 25 references

Sorted by citations

Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
The changing scene of amyotrophic lateral sclerosis
Robberecht, W., & Philips, T. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3430 · Cited by 957
Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function
Raivich, G., Bohatschek, M., Kloss, C. U. A., Werner, A., Jones, L. L., & Kreutzberg, G. W. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00007-7 · Cited by 843
The blood–brain barrier in health and disease
Daneman, R. (2012) · Annals of Neurology · doi:10.1002/ana.23648 · Cited by 794
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study
Turner, M. R., Cagnin, A., Turkheimer, F. E., Miller, C. C. J., Shaw, C. E., Brooks, D. J., Leigh, P. N., & Banati, R. B. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.012 · Cited by 737
Immune activation in brain aging and neurodegeneration: too much or too little?
Lucin, K. M., & Wyss-Coray, T. (2009) · Neuron · doi:10.1016/j.neuron.2009.08.039 · Cited by 679
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
Philips, T., & Robberecht, W. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70015-1 · Cited by 646
Presence of dendritic cells, MCP‐1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue
Henkel-Tigges, J., Engelhardt, J., Siklós, L., Simpson, E. P., Kim, S. H., Pan, T., Goodman, J. C., Siddique, T., Beers, D. R., & Appel, S. H. (2003) · Annals of Neurology · doi:10.1002/ana.10805 · Cited by 576
Self-citation
The AP-1 Transcription Factor c-Jun Is Required for Efficient Axonal Regeneration
Raivich, G., Bohatschek, M., Costa, C. D., Iwata, O., Galiano, M., Hristova, M., Nateri, A. S., Makwana, M., Riera-Sans, L., Wolfer, D. P., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.005 · Cited by 487
Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases
Neumann, H. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02154-9 · Cited by 480
Inflammatory processes in amyotrophic lateral sclerosis
McGeer, P. L., & McGeer, E. G. (2002) · Muscle & Nerve · doi:10.1002/mus.10191 · Cited by 470
Immune reactivity in a mouse model of familial ALS correlates with disease progression
Alexianu, M. E., Kozovska, M., & Appel, S. H. (2001) · Neurology · doi:10.1212/wnl.57.7.1282 · Cited by 438
Self-citation
Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis
Beers, D. R., Henkel-Tigges, J., Zhao, W., Wang, J., Huang, A., Wen, S., Liao, B., & Appel, S. H. (2011) · Brain · doi:10.1093/brain/awr074 · Cited by 439
Self-citation
Immune cell regulation of glia during CNS injury and disease
Greenhalgh, A. D., David, S., & Bennett, F. C. (2020) · Nature reviews. Neuroscience · doi:10.1038/s41583-020-0263-9 · Cited by 411
Neuroinflammation: Microglia and T Cells Get Ready to Tango
Schetters, S. T. T., Gómez‐Nicola, D., García-Vallejo, J. J., & van Kooyk, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01905 · Cited by 400
Regulatory T‐lymphocytes mediate amyotrophic lateral sclerosis progression and survival
Henkel-Tigges, J., Beers, D. R., Wen, S., Rivera, A. L., Toennis, K. M., Appel, J. E., Zhao, W., Moore, D. H., Powell, S. Z.-E., & Appel, S. H. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201544 · Cited by 355
Self-citation
Blood–spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis
Winkler, E. A., Sengillo, J. D., Sullivan, J. S., Henkel, J. S., Appel, S. H., & Zlokovic, B. V. (2013) · Acta Neuropathologica · doi:10.1007/s00401-012-1039-8 · Cited by 354
Self-citation
Microglia in ALS: The Good, The Bad, and The Resting
Henkel, J. S., Beers, D. R., Zhao, W., & Appel, S. H. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9171-5 · Cited by 353
Self-citation
Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum
He, Y., Appel, S. H., & Le, W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02681-6 · Cited by 350
Self-citation
Increased lipid peroxidation in sera of ALS patients
Simpson, E. P., Henry, Y. K., Henkel-Tigges, J., Smith, R. G., & Appel, S. H. (2004) · Neurology · doi:10.1212/wnl.62.10.1758 · Cited by 328
Self-citation
Inflammation in ALS/FTD pathogenesis
McCauley, M. E., & Baloh, R. H. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1933-9 · Cited by 341
Control of glial immune function by neurons
Neumann, H. (2001) · Glia · doi:10.1002/glia.1108 · Cited by 319
Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis
Hooten, K. G., Beers, D. R., Zhao, W., & Appel, S. H. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0329-3 · Cited by 294
Self-citation
Immune Surveillance in the Injured Nervous System: T-Lymphocytes Invade the Axotomized Mouse Facial Motor Nucleus and Aggregate around Sites of Neuronal Degeneration
Raivich, G., Jones, L. L., Kloss, C. U. A., Werner, A., Neumann, H., & Kreutzberg, G. W. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-15-05804.1998 · Cited by 273
Immune aging, dysmetabolism, and inflammation in neurological diseases
Deleidi, M., JÃ¤ggle, M., & Rubino, G. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00172 · Cited by 260
T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?
Appel, S. H., Beers, D. R., & Henkel, J. S. (2010) · Trends in Immunology · doi:10.1016/j.it.2009.09.003 · Cited by 256
Self-citation
ALS patients’ regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity
Beers, D. R., Zhao, W., Wang, J., Zhang, X., Wen, S., Neal, D. W., Thonhoff, J. R., Alsuliman, A., Shpall, E. J., Rezvani, K., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89530 · Cited by 267
Self-citation
Glial cells in amyotrophic lateral sclerosis
Philips, T., & Rothstein, J. D. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.05.015 · Cited by 266
Evidence of Compromised Blood-Spinal Cord Barrier in Early and Late Symptomatic SOD1 Mice Modeling ALS
Garbuzova-Davis, S. N., Saporta, S., Haller, E. M., Kolomey, I., Bennett, S. P., Potter, H., & Sanberg, P. R. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001205 · Cited by 253
Ultrastructure of blood–brain barrier and blood–spinal cord barrier in SOD1 mice modeling ALS
Garbuzova-Davis, S., Haller, E., Saporta, S., Kolomey, I., Nicosia, S. V., & Sanberg, P. R. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.044 · Cited by 239
The Role of Immune and Inflammatory Mechanisms in ALS
McCombe, P., & Henderson, R. D. (2011) · Current Molecular Medicine · doi:10.2174/156652411795243450 · Cited by 238
The Role of Sex and Sex Hormones in Neurodegenerative Diseases
Vegeto, E., Villa, A. M., Torre, S. D., Crippa, V., Rusmini, P., Cristofani, R., Galbiati, M., Maggi, A. C., & Poletti, A. (2019) · Endocrine Reviews · doi:10.1210/endrev/bnz005 · Cited by 240
The immunology of neurodegeneration
Czirr, E., & Wyss‐Coray, T. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58656 · Cited by 218
Astrocyte-Derived TGF-β1 Accelerates Disease Progression in ALS Mice by Interfering with the Neuroprotective Functions of Microglia and T Cells
Endo, F., Komine, O., Fujimori-Tonou, N., Katsuno, M., Jin, S., Watanabe, S., Sobue, G., Dezawa, M., Wyss-Coray, T., & Yamanaka, K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.053 · Cited by 207
Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression
Murdock, B. J., Zhou, T., Kashlan, S. R., Little, R. J. A., Goutman, S. A., & Feldman, E. L. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.2255 · Cited by 212
Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice
Beers, D. R., Zhao, W., Liao, B., Kano, O., Wang, J., Huang, A., Appel, S. H., & Henkel-Tigges, J. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.12.008 · Cited by 207
Self-citation
Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process
Mantovani, S., Garbelli, S., Pasini, A., Alimonti, D., Perotti, C. G., Melazzini, M. G., Bendotti, C., & Mora, G. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.02.012 · Cited by 190
Mis-spliced transcripts generate de novo proteins in TDP-43–related ALS/FTD
Seddighi, S., Qi, Y. A., Brown, A., Wilkins, O. G., Bereda, C., Belair, C., Zhang, Y., Prudencio, M., Keuss, M. J., Khandeshi, A. J., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adg7162 · Cited by 200
A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis
Mitchell, R. M., Freeman, W. M., Randazzo, W. T., Stephens, H., Beard, J. L., Simmons, Z., & Connor, J. R. (2008) · Neurology · doi:10.1212/01.wnl.0000333251.36681.a5 · Cited by 184
The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS
Henkel-Tigges, J., Beers, D. R., Siklós, L., & Appel, S. H. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.10.016 · Cited by 181
Self-citation
Inflammation and neurovascular changes in amyotrophic lateral sclerosis
Evans, M. C., Couch, Y., Sibson, N. R., & Turner, M. R. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.10.008 · Cited by 174
Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis
Sheean, R. K., McKay, F. C., Cretney, E., Bye, C. R., Perera, N. D., Tomas, D., Weston, R. A., Scheller, K. J., Djouma, E., Menon, P., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0035 · Cited by 184
Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
Lall, D., & Baloh, R. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90607 · Cited by 175
Mutant SOD1G93A microglia are more neurotoxic relative to wild‐type microglia
Xiao, Q., Zhao, W., Beers, D. R., Yen, A. A., Xie, W., Henkel, J. S., & Appel, S. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04677.x · Cited by 174
Self-citation
Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?
Mayne, K., White, J. A., McMurran, C. E., Rivera, F. J., & de la Fuente, A. G. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.572090 · Cited by 167
The microglial component of amyotrophic lateral sclerosis
Clarke, B. E., & Patani, R. (2020) · Brain · doi:10.1093/brain/awaa309 · Cited by 164
Neuroinflammation, COX-2, and ALS—a dual role?
Consilvio, C., Vincent, A. M., & Feldman, E. L. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.12.009 · Cited by 155
The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis
Pollari, E., Goldsteins, G., Bart, G., Koıstınaho, J., & Giniatullin, R. A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00131 · Cited by 151
Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases
Staff, N. P., Jones, D. T., & Singer, W. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.01.001 · Cited by 150
Blood-CNS Barrier Impairment in ALS patients versus an animal model
Garbuzova-Davis, S. N., & Sanberg, P. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00021 · Cited by 152
Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis
Brettschneider, J., Libon, D. J., Toledo, J. B., Xie, S. X., McCluskey, L., Elman, L., Geser, F., Lee, V. M.-Y., Grossman, M., & Trojanowski, J. Q. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0932-x · Cited by 142
Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms
Zhao, W., Beers, D. R., Liao, B., Henkel-Tigges, J., & Appel, S. H. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.07.008 · Cited by 143
Self-citation
Cytotoxic CD8 + T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneurons
Coque, E., Salsac, C., Espinosa-Carrasco, G., Varga, B., Degauque, N., Cadoux, M., Crabé, R., Virenque, A., Soulard, C., Fierle, J. K., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815961116 · Cited by 136
Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders
Machhi, J., Kevadiya, B. D., Muhammad, I. K., Herskovitz, J., Olson, K. E., Mosley, R. L., & Gendelman, H. E. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00375-7 · Cited by 138
Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosis
Nagy, D., Kato, T., & Kushner, P. D. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490380312 · Cited by 131
Amyotrophic lateral sclerosis: A neurovascular disease
Garbuzova-Davis, S. N., Rodrigues, M. C. O., Hernandez‐Ontiveros, D. G., Louis, M. K., Willing, A. E., Borlongan, C. V., & Sanberg, P. R. (2011) · Brain Research · doi:10.1016/j.brainres.2011.04.049 · Cited by 128
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses
Béland, L.-C., Markovinovic, A., Jakovac, H., De Marchi, F., Bilic, E., Mazzini, L., Kriz, J., & Munitic, I. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa124 · Cited by 125
Differential contribution of microglia and monocytes in neurodegenerative diseases
Baufeld, C., O'Loughlin, E. K., Calcagno, N., Madore, C., & Butovsky, O. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1795-7 · Cited by 128
Molecular Signals for Glial Activation: Pro- and Anti-Inflammatory Cytokines in the Injured Brain
Raivich, G., Jones, L. L., Werner, A., Blüthmann, H., Doetschmann, T., & Kreutzberg, G. W. (1999) · Acta neurochirurgica. Supplementum · doi:10.1007/978-3-7091-6391-7_4 · Cited by 123
Evidence for autoimmunity in amyotrophic lateral sclerosis
Appel, S. H., Smith, R. G., Engelhardt, J. I., & Stefani, E. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90106-9 · Cited by 121
Self-citation
Alterations of T cell subsets in ALS: a systemic immune activation?
Rentzos, M., Evangelopoulos, M., Sereti, E., Zouvelou, V., Marmara, S., Alexakis, T., & Evdokimidis, I. (2011) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2011.01528.x · Cited by 125
From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis
Lincecum, J. M., Vieira, F. G., Wang, M. Z., Thompson, K., Zutter, G. S. D., Kidd, J. D., Moreno, A., Sànchez, R., Carrion, I. J., Levine, B. A., et al. (2010) · Nature Genetics · doi:10.1038/ng.557 · Cited by 118
T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression
Yazdani, S., Seitz, C., Cui, C., Lovik, A., Pan, L., Piehl, F., Yudi Pawitan, Y., Kläppe, U., Press, R., Samuelsson, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34526-9 · Cited by 113
Amyotrophic Lateral Sclerosis: A Neurodegenerative Motor Neuron Disease With Ocular Involvement
Rojas, P., Ramirez, A. I., Fernández‐Albarral, J. A., López‐Cuenca, I., Salobrar‐García, E., Cadena, M., Elvira‐Hurtado, L., Salazar, J. J., de Hoz, R., & Ramirez, J. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.566858 · Cited by 117
Glial Cells in Amyotrophic Lateral Sclerosis
Lasiene, J., & Yamanaka, K. (2011) · Neurology Research International · doi:10.1155/2011/718987 · Cited by 110
ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression
Quek, H., Cuní‐López, C., Stewart, R., Colletti, T., Notaro, A., Sun, Y., Guo, C. C., Lupton, M. K., Nguyen, T. H., Oikari, L. E., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02421-1 · Cited by 108
Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation?
Rentzos, M., Rombos, A., Nikolaou, C., Zoga, M., Zouvelou, V., Dimitrakopoulos, A., Alexakis, T., Tsoutsou, A., Samakovli, A., Michalopoulou, M., et al. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01333.x · Cited by 104
Humoral factors in ALS patients during disease progression
Ehrhart, J. C., de Smith, A. J., Kuzmin‐Nichols, N., Zesiewicz, T., Jahan, I., Shytle, R. D., Kim, S.-H., Sanberg, C. D., Vu, T., Gooch, C. L., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0350-4 · Cited by 106
T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease
Williams, G. P., Marmion, D. J., Schonhoff, A. M., Jurkuvenaite, A., Won, W.-J., Standaert, D. G., Kordower, J. H., & Harms, A. S. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02126-w · Cited by 102
Biphasic Mechanisms of Neurovascular Unit Injury and Protection in CNS Diseases
Maki, T., Hayakawa, K., Pham, L. D., Xing, C., Lo, E. H., & Arai, K. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312030004 · Cited by 103
Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms
Figueroa‐Romero, C., Hur, J., Lunn, J. S., Paez-Colasante, X., Bender, D. E., Yung, R. L., Sakowski, S. A., & Feldman, E. L. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.12.008 · Cited by 106
Evidence for Fungal Infection in Cerebrospinal Fluid and Brain Tissue from Patients with Amyotrophic Lateral Sclerosis
Alonso, R., Pisa, D., Marina, A., Morato, E., Rábano, A., Rodal, I., & Carrasco, L. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.11084 · Cited by 100
Temporal evolution of the microbiome, immune system, and epigenome with disease progression in ALS mice
Figueroa-Romero, C., Guo, K., Murdock, B. J., Paez-Colasante, X., Bassis, C. M., Mikhail, K. A., Raue, K. D., Evans, M. C., Taubman, G. F., McDermott, A. J., et al. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.041947 · Cited by 94
TNF and sTNFR1/2 plasma levels in ALS patients
Cereda, C., Baiocchi, C., Bongioanni, P., Cova, E., Guareschi, S., Metelli, M. R., Rossi, B., Sbalsi, I., Cuccia, M. C., & Ceroni, M. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.10.028 · Cited by 94
TRPM7 and TRPM2—Candidate susceptibility genes for Western Pacific ALS and PD?
Hermosura, M. C., & Garruto, R. M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.02.008 · Cited by 94
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
Rizzo, F., Riboldi, G. M., Salani, S., Nizzardo, M., Simone, C., Corti, S. P., & Hedlund, E. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1480-4 · Cited by 93
Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective
Malaspina, A., Puentes, F., & Amor, S. (2014) · International Immunology · doi:10.1093/intimm/dxu099 · Cited by 92
Neuroinflammation in motor neuron disease
Endo, F., Komine, O., & Yamanaka, K. (2016) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12309 · Cited by 95
The contribution of the peripheral immune system to neurodegeneration
Berriat, F., Lobsiger, C. S., & Boillée, S. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01323-6 · Cited by 87
Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4
Campisi, L., Chizari, S., Ho, J., Gromova, A., Arnold, F. J., Mosca, L., Mei, X., Fstkchyan, Y. S., Torre, D., Beharry, C., et al. (2022) · Nature · doi:10.1038/s41586-022-04844-5 · Cited by 91
Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis
Gustafson, M. P., Staff, N. P., Bornschlegl, S., Butler, G. W., Maas, M. L., Kazamel, M., Zubair, A. S., Gastineau, D. A., Windebank, A. J., & Dietz, A. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182002 · Cited by 89
Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology
Lyon, M. S., Wosiski‐Kuhn, M., Gillespie, R., Caress, J. B., & Milligan, C. (2018) · Muscle & Nerve · doi:10.1002/mus.26289 · Cited by 94
Neuroinflammation in motor neuron disease.
Komine, O., & Yamanaka, K. (2015) · Europe PMC (PubMed Central) · doi:10.18999/nagjms.77.4.537 · Cited by 87
The multifaceted role of glial cells in amyotrophic lateral sclerosis
Valori, C. F., Brambilla, L., Martorana, F., & Rossi, D. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1429-7 · Cited by 88
T cells in amyotrophic lateral sclerosis
Holmøy, T. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02065.x · Cited by 78
Protective and Regenerative Roles of T Cells in Central Nervous System Disorders
Evans, F., Dittmer, M., de la Fuente, A. G., & Fitzgerald, D. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02171 · Cited by 80
The Neuroinflammatory Response in ALS: The Roles of Microglia and T Cells
Lewis, C.-A., Manning, J., Rossi, F., & Krieger, C. (2012) · Neurology Research International · doi:10.1155/2012/803701 · Cited by 76
Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
Filipi, T., Heřmanová, Z., Turečková, J., Vaňátko, O., & Anděrová, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010261 · Cited by 76
The dual roles of immunity in ALS: Injury overrides protection
Murdock, B. J., Bender, D. E., Segal, B. M., & Feldman, E. L. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.017 · Cited by 74
The role of inflammation in neurodegeneration: novel insights into the role of the immune system in C9orf72 HRE-mediated ALS/FTD
Masrori, P., Beckers, J., Gossye, H., & Damme, P. V. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00525-z · Cited by 80
Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy.
Gussoni, E., Pavlath, G. K., Miller, R. G., Panzara, M. A., Powell, M. E. A., Blau, H. M., & Steinman, L. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4798 · Cited by 70
The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients
Kwon, M., Noh, M., Oh, K., Cho, K., Kang, B., Kim, K., Kim, Y., & Kim, S. H. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12814 · Cited by 70
High neutrophil-to-lymphocyte ratio predicts short survival duration in amyotrophic lateral sclerosis
Choi, S., Hong, Y., Kim, S., Shin, J.-Y., Suh, Y. J., & Sung, J. (2020) · Scientific Reports · doi:10.1038/s41598-019-57366-y · Cited by 69
Repeated courses of granulocyte colony‐stimulating factor in amyotrophic lateral sclerosis: Clinical and biological results from a prospective multicenter study
Chiò, A., Mora, G., Bella, V. L., Caponnetto, C., Mancardi, G., Sabatelli, M., Siciliano, G., Silani, V., Corbo, M., Moglia, C., et al. (2011) · Muscle & Nerve · doi:10.1002/mus.21851 · Cited by 69
Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis
Potenza, R. L., De Simone, R., Armida, M., Mazziotti, V., Pèzzola, A., Popoli, P., & Minghetti, L. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0462-2 · Cited by 69
Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis
Liu, Z., Cheng, X., Zhong, S., Zhang, X., Liu, C., Liu, F., & Zhao, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00575 · Cited by 68
How the immune system shapes neurodegenerative diseases
Mason, H. D., & McGavern, D. B. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.08.001 · Cited by 67
Blood-CNS barrier dysfunction in amyotrophic lateral sclerosis: Proposed mechanisms and clinical implications
Steinruecke, M., Lonergan, R. M., Selvaraj, B. T., Chandran, S., Castro, B. D., & Stavrou, M. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231153281 · Cited by 63
Current Advances and Limitations in Modeling ALS/FTD in a Dish Using Induced Pluripotent Stem Cells
Guo, W., Fumagalli, L., Prior, R. C., & Bosch, L. V. D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00671 · Cited by 65
Passive transfer of purified IgG from patients with amyotrophic lateral sclerosis to mice results in degeneration of motor neurons accompanied by Ca 2+ enhancement
Pullen, A. H., Demestre, M., Howard, R., & Orrell, R. W. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0777-z · Cited by 62

Authors: Engelhardt, J. I., Tajti, J., & Appel, S. H.
Affiliations: Baylor College of Medicine (US)
ORCID: Tajti, J.
Appel, S. H.
Venue: Archives of Neurology
Publisher: American Medical Association (AMA)
Published: 1993-01-01
Volume: 50
Issue: 1
Pages: 30-36
ISSN: 0003-9942 (ISSN-L)
DOI: 10.1001/archneur.1993.00540010026013
OpenAlex: W2069781018
Cited by: 318
References: 25
Citations by year: 2026: 8 · 2025: 9 · 2024: 14 · 2023: 19 · 2022: 20 · 2021: 10 · 2020: 16 · 2019: 14 · 2018: 15 · 2017: 11 · 2016: 12 · 2015: 14 · 2014: 10 · 2013: 14 · 2012: 19
FWCI: 5.43
Type: journal article
Language: en
Open access: closed
Locations: Archives of Neurology (publishedVersion)
PubMed (publishedVersion)
SZTE Publicatio Repozitórium (University of Szeged) (acceptedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: amyotrophic lateral sclerosis, spinal cord, lymphocyte infiltration, T cells, T helper cells, suppressor/cytotoxic T cells, corticospinal tract degeneration, ventral horn, B cells, CD45, CD4, CD8, neuroinflammation
MeSH terms: Adult, Aged, Amyotrophic Lateral Sclerosis, B-Lymphocytes, Female, Humans, Male, Middle Aged, Spinal Cord, CD4-Positive T-Lymphocytes, CD4 Antigens, CD8 Antigens, Leukocyte Common Antigens, T-Lymphocytes, Regulatory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Lymphocytic Infiltrates in the Spinal Cord in Amyotrophic Lateral Sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks